Recent progress in the development of adenosine receptor ligands as antiinflammatory drugs.
about
Adenosine kinase: exploitation for therapeutic gain.Emerging adenosine receptor agonistsSuppression of inflammatory and immune responses by the A(2A) adenosine receptor: an introduction.Adenosine and the auditory system.Search for new antagonist ligands for adenosine receptors from QSAR point of view. How close are we?Xanthines as adenosine receptor antagonists.Adenosine receptor subtype-selective antagonists in inflammation and hyperalgesia.Synthesis of (R)-3,4-dihydro-2H-pyran-2-carboxaldehyde: application to the synthesis of potent adenosine A(2A) and A(3) receptor agonist.Therapeutic potential of adenosine receptor antagonists and agonists.Adenosine receptors as drug targets.Novel strategies for the treatment of inflammatory hyperalgesia.Newer glucocorticosteroids and corticosteroid resistance reversal in asthma.Moonlighting adenosine deaminase: a target protein for drug development.Pyrazin-2(1H)-ones as a novel class of selective A3 adenosine receptor antagonists.Development of Polar Adenosine A2A Receptor Agonists for Inflammatory Bowel Disease: Synergism with A2B Antagonists.Azide-tetrazole equilibrium of C-6 azidopurine nucleosides and their ligation reactions with alkynesSelectivity is species-dependent: Characterization of standard agonists and antagonists at human, rat, and mouse adenosine receptors.Safety and efficacy of combination therapy of iguratimod with methotrexate for patients with active rheumatoid arthritis with an inadequate response to methotrexate: an open-label extension of a randomized, double-blind, placebo-controlled trial.Progress in the discovery of selective, high affinity A(2B) adenosine receptor antagonists as clinical candidates.Normalization of A2A and A3 adenosine receptor up-regulation in rheumatoid arthritis patients by treatment with anti-tumor necrosis factor alpha but not methotrexate.Concomitant iguratimod therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate: a randomized, double-blind, placebo-controlled trial.Ectonucleotidase inhibitors: a patent review (2011-2016).A1 -Adenosine receptor activation has biphasic roles in development of acute kidney injury at 4 and 24 h of reperfusion following ischaemia in rats.Novel water-soluble lignin derivative BP-Cx-1: identification of components and screening of potential targets in silico and in vitro.Adenosine A2A receptor contributes to the anti-inflammatory effect of the fixed herbal combination STW 5 (Iberogast®) in rat small intestinal preparations.Metabolomics coupled with pathway analysis characterizes metabolic changes in response to BDE-3 induced reproductive toxicity in mice.
P2860
Q26852056-194EF735-74D1-4181-AD0A-F91D445748ABQ28249111-32073784-850C-47D2-BAC0-24CF40FF764CQ30440124-D0C719C9-AD28-46F0-B20C-F7D2E87A9A53Q30482911-7B909873-9A34-446E-BD93-7525FA489DC9Q33292715-78385F87-E9D2-42F7-BFAB-AE86E3415157Q34139398-B126B22F-9AF9-4222-B2A0-5A8D3134BAD8Q34734932-E90E90F7-BBDF-46ED-98CD-8E01D93C7288Q37185339-B40F846E-5B48-480B-862F-0877F9B4C08CQ37689793-1DDD3C0D-5887-473B-A892-B7A9DA872287Q37691817-0B55F5B0-E8F1-4CE3-8E25-3654ED24E761Q37692191-2212801A-195F-4298-ACEF-DCACA4F9D2BAQ38162976-EF39F125-E123-4432-AB34-0532977A86A2Q38220597-EB329F35-1DC3-4C8C-80BC-261DF299E22AQ38979023-11F5208D-A3A4-4074-839A-EA251CACDA1CQ39514425-40F87FAC-F179-46B2-A594-AAD3CB6AC434Q40775396-922B3EBA-5DA0-4E2B-9C20-222CC1AD8235Q40781522-4FC906B9-FB26-41AC-A10F-FCAFD13BD0A1Q42628958-A9AFB965-5FB9-496E-8B11-1677BADD8EDCQ42952282-B537691E-B371-4A02-9606-86C8B65654F0Q43269361-316AB58D-BEAA-4533-92E9-433EE158EF6EQ46723428-FD236E30-F4A5-4578-9FBA-9BAF80FD93B5Q50224587-6AF70229-6783-48D1-B046-A78572214ECBQ52671079-7ABE59BB-4955-4A18-B9C6-EAC0AF192A9CQ53950685-A88CEFDB-84FF-4BD5-AD5E-C7EB41DC278BQ54334590-9CA68333-219E-4E9B-BDC0-3ACC0554239DQ54967101-2699C6A0-85E2-4D1C-9A2A-437503FF361A
P2860
Recent progress in the development of adenosine receptor ligands as antiinflammatory drugs.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Recent progress in the develop ...... nds as antiinflammatory drugs.
@ast
Recent progress in the develop ...... nds as antiinflammatory drugs.
@en
type
label
Recent progress in the develop ...... nds as antiinflammatory drugs.
@ast
Recent progress in the develop ...... nds as antiinflammatory drugs.
@en
prefLabel
Recent progress in the develop ...... nds as antiinflammatory drugs.
@ast
Recent progress in the develop ...... nds as antiinflammatory drugs.
@en
P2093
P1476
Recent progress in the develop ...... nds as antiinflammatory drugs.
@en
P2093
Christa E Müller
Joachim C Burbiel
Jörg Hockemeyer
Rhalid Akkari
P304
P356
10.2174/15680266106061375
P577
2006-01-01T00:00:00Z